Skip to Content
WASHINGTON – U.S. Representative Pramila Jayapal (WA-07) released the following statement regarding her vote against H.R. 7521, the Protecting Americans from Foreign Adversary Controlled Applications Act. The legislation today passed the House by a vote of 352-65.
“I voted no…
Issues:
Foreign Affairs & National Security,
Science, Technology, & Antitrust
Warren, Jayapal Announce Three Drug Manufacturers Pulled Sham Patents after Warnings, Urge FDA to Continue Fight Against Big Pharma Companies’ Patent Abuse
Lawmakers Probed Big Pharma’s Sham Patent Claims after FTC Warnings in December 2023; Are Now Sharing Responses with…
Issues:
Health Care,
Science, Technology, & Antitrust
Members of CHIPS Investment Team Passed Through Revolving Door Between Government and Wall Street, Risking Misuse of Taxpayer Dollars
“Instead of building a broad-based team of experts from different sectors of government and the private sector, the Department has ‘been…
Issues:
Government Reform & Ethics,
Science, Technology, & Antitrust
WASHINGTON – U.S. Representatives Pramila Jayapal (WA-07), a member of the House Antitrust Subcommittee, and Jerrold Nadler (NY-12), Ranking Member of the Judiciary Committee, are today urging the Administration to consider judicial nominees’ records on antitrust and competition policy during…
Issues:
Science, Technology, & Antitrust
Washington (October 30, 2023) – Congresswoman Pramila Jayapal (WA-07) and Senator Edward J. Markey (D-Mass.) applauded the Biden administration for heeding their call to incorporate the White House Blueprint for an AI Bill of Rights into its artificial intelligence (AI)…
Issues:
Science, Technology, & Antitrust
Their letter echoes a recent call from more than 60 civil society organizations
Lawmakers: “the federal government’s commitment to the AI Bill of Rights would show that fundamental rights will not take a back seat in the AI era”
Letter…
Issues:
Science, Technology, & Antitrust
